Physician profile
Robert P Goolsby
NPI 1720054224
$2,694.71
in general payments reported to CMS, 2019-2025
37 companies · $14.31 in 2025
The $14.31 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $673 · 2020: $354 · 2021: $522 · 2022: $383 · 2023: $444 · 2024: $304 · 2025: $14.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $762.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $649.52 | 2019-2024 | |
| Astellas Pharma US INC | $441.05 | 2019-2024 | Veozah, Myrbetriq |
| Mylan Pharmaceuticals INC. | $142.12 | 2019-2022 | |
| Amgen INC. | $133.49 | 2019-2025 | Evenity |
| Therapeuticsmd, INC. | $132.24 | 2019-2022 | |
| Shield Therapeutics INC | $99.66 | 2022-2024 | Accrufer |
| Scynexis, INC. | $85.60 | 2022 | |
| Hologic Sales and Service, LLC | $84.44 | 2020-2023 | Aptima |
| Exeltis, USA INC. | $68.16 | 2020-2023 | Slynd |
| Coopersurgical, INC. | $67.51 | 2020-2021 | |
| Ethicon US, LLC | $51.52 | 2019-2021 | |
| Virtus Pharmaceuticals LLC | $49.20 | 2021 | |
| Vertical Pharmaceuticals, LLC | $47.99 | 2019-2020 | |
| Aspira Women'S Health INC | $44.99 | 2021 | |
| Novo Nordisk INC | $41.90 | 2019-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $41.21 | 2023-2024 | |
| Sage Therapeutics, LLC | $37.42 | 2024 | |
| Axonics, INC. | $37.26 | 2023 | Axonics |
| Evofem Biosciences, INC. | $36.81 | 2022 | |
| Convatec INC. | $34.54 | 2019 | |
| Millicent US INC | $33.61 | 2023-2024 | Femring, Intrarosa |
| Exact Sciences Corporation | $32.60 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $31.13 | 2020-2024 | Zepbound |
| Amag Pharmaceuticals, INC. | $30.30 | 2019 | |
| Organon LLC | $27.70 | 2022-2023 | Jada System |
| Becton, Dickinson and Company | $26.97 | 2022-2023 | Bd Onclarity |
| Sumitomo Pharma America, INC. | $24.32 | 2023 | Gemtesa |
| Roche Diagnostics Corporation | $21.40 | 2019 | |
| Daiichi Sankyo INC. | $20.67 | 2019 | |
| Lundbeck LLC | $20.40 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.20 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.70 | 2023 | Seglentis, Livalo |
| Lsi Solutions INC | $14.27 | 2021 | |
| Mayne Pharma Commercial LLC | $13.72 | 2022 | |
| Coloplast Corp | $12.56 | 2021 | |
| Lupin INC. | $12.00 | 2019 | |
| Mission Pharmacal Company | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Goolsby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.